Transcode Therapeutics, Inc. Quarterly Assets in USD from Q4 2020 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Transcode Therapeutics, Inc. quarterly Assets history and growth rate from Q4 2020 to Q3 2024.
Transcode Therapeutics, Inc. Assets for the quarter ending September 30, 2024 was $3.94M, a 61.5% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$3.94M	-$6.29M	-61.5%	Sep 30, 2024	10-Q	2024-11-14
Q2 2024	$4.82M	-$1.06M	-18%	Jun 30, 2024	10-Q	2024-08-14
Q1 2024	$7.29M	+$1.7M	+30.4%	Mar 31, 2024	10-Q	2024-05-15
Q4 2023	$5.17M	-$2.42M	-31.9%	Dec 31, 2023	10-Q	2024-11-14
Q3 2023	$10.2M	-$1.79M	-14.9%	Sep 30, 2023	10-Q	2023-11-14
Q2 2023	$5.88M	-$8.27M	-58.5%	Jun 30, 2023	10-Q	2023-08-14
Q1 2023	$5.59M	-$13.3M	-70.3%	Mar 31, 2023	10-Q	2023-05-15
Q4 2022	$7.59M	-$15.4M	-66.9%	Dec 31, 2022	10-K	2024-04-01
Q3 2022	$12M	-$13.3M	-52.6%	Sep 30, 2022	10-Q	2022-11-14
Q2 2022	$14.2M	+$12.6M	+830%	Jun 30, 2022	10-Q	2022-08-15
Q1 2022	$18.9M			Mar 31, 2022	10-Q	2022-05-16
Q4 2021	$22.9M	+$21.9M	+2074%	Dec 31, 2021	10-K	2023-03-31
Q3 2021	$25.4M			Sep 30, 2021	10-Q	2021-11-15
Q2 2021	$1.52M			Jun 30, 2021	10-Q	2021-08-23
Q4 2020	$1.06M			Dec 31, 2020	10-K	2022-03-31

* An asterisk sign (*) next to the value indicates that the value is likely invalid.